“…These are further subdivided into DN1 (CD44 + CD25 - ), DN2 (CD44 + CD25 + ), DN3 (CD44 - CD25 + ) and DN4 (CD44CD25 - ) stages. αβ and γδ development is thought to bifurcate at the DN2b>DN3 transition, when TCRB/G/D gene rearrangement occurs to generate a functional pre-TCR or γδ TCR (Ciofani, Knowles, Wiest, von Boehmer, & Zuniga-Pflucker, 2006; Fehling, Krotkova, Saint-Ruf, & von Boehmer, 1995; Kreslavsky, Gleimer, Garbe, & von Boehmer, 2010; Oh, Gray, & Chong, 2021). Evidence also suggests that effector outcomes of γδ T cells may also be determined in the thymus rather than in the periphery because the expression of IL-17A and IFNγ by mature cells correlates with Vγ chain usage.…”